← Eichor
Study identifier: NCT02060565 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease

Condition: Chronic Liver Disease  ·  Sponsor: Association HGE CHU Bordeaux Sud

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.

This description comes directly from the study's public registry record.

Talk to the study team

Victor de Lédinghen, MD, PhD  ·  0033557656439  ·  victor.deledinghen@chu-bordeaux.fr

Juliette Foucher  ·  0033557656439  ·  juliette.foucher@chu-bordeaux.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre d'Investigation de la Fibrose hépatique Service Hépato-Gastroentérologie Hopital Haut-LévèquePessac, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02060565